Revenue fell 6.4% year-over-year to $2.93 billion, slightly ahead of analyst consensus at ~$2.90 billion AInvest.
Automotive: flat YoY at ~$1.73 billion
Industrial & IoT: down ~11%
Communications & Infrastructure: sharp drop of ~27% AInvest
EPS: Adjusted EPS of $2.72 exceeded Zacks consensus of $2.66 Bloomberg.com.
Margins & Cash Flow:
Gross margin ~56.5%, operating margin ~32%
Free cash flow reached $696 million
Forecasted revenue range: $3.05B–$3.25B (midpoint$3.15B), slightly above Wall Street consensus ($3.07B–$3.08B), but below some analyst expectations of $3.3B .
Adjusted EPS projected between $2.89–$3.30, aligning with estimates AInvest.
Investors were hoping for clearer signs of recovery—especially given NXP’s exposure to resilient automotive markets—so the guidance fell short of their hopes FINVIZ.
Stock response: Dropped ~4.7–5% in after-hours trading, erasing earlier intraday gains Reutersinvestorshangout.com.
Analysts: Mixed views:
Some see it as a cyclical setback—automotive and industrial demand uneven, macro pressure, uncertain tariff environment AInvest.
Others call it a buying opportunity—strong cash flow, robust margins, long-term positioning in autonomous driving, edge AI, and IoT AInvest.
Valuation: Plummeted compared to peers—trading around 12× forward P/E for FY26, well below the ~39× sector average AInvest.
Automotive & ADAS: Continued R&D in automotive microcontrollers and radar processors; acquisition of TTTech Auto; partnerships (e.g., Rimac) bolster future self-driving tech AInvest.
Edge AI: Purchase of Kinara targets artificial intelligence chips for edge computing devices—supporting broader smart infrastructure Reuters2.
Geopolitical resilience: Latin with on-shoring/investment in China R&D to hedge against trade disruptions AInvest.
Near-term: The soft guidance amid macro and demand volatility weighed on sentiment—evident in the post-market drop.
Long-term: NXP remains well-positioned in high-growth areas like automotive electronics, ADAS, IoT, and edge AI. With healthy margins and strong cash flows, the pullback may present an entry point for patient investors.